Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation. [electronic resource]
Producer: 20130624Description: 421-9 p. digitalISSN:- 1878-1810
- Adenosine Diphosphate -- pharmacology
- Aged
- Angioplasty -- adverse effects
- Blood Platelets -- metabolism
- Case-Control Studies
- Cell Adhesion Molecules -- blood
- Clopidogrel
- Female
- Humans
- Male
- Microfilament Proteins -- blood
- Middle Aged
- Obesity -- blood
- P-Selectin -- blood
- Phosphoproteins -- blood
- Platelet Activation -- drug effects
- Platelet Aggregation Inhibitors -- pharmacology
- Platelet Glycoprotein GPIIb-IIIa Complex -- metabolism
- Receptor, PAR-1 -- blood
- Stents -- adverse effects
- Thrombosis -- blood
- Ticlopidine -- analogs & derivatives
- Translational Research, Biomedical
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.